Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors

Journal of Immunology

Volumn 193, Issue 6, 2014, Pages 3155-3164

  Ryzhov, Sergey V ^a   Pickup, Michael W ^b   Chytil, Anna ^b   Gorska, Agnieszka E ^b   Zhang, Qinkun ^a   Owens, Philip ^b   Feoktistov, Igor ^a   Moses, Harold L ^b   Novitskiy, Sergey V ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; CD39 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; APYRASE; LEUKOCYTE ANTIGEN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL DENSITY; BLOOD VESSEL PARAMETERS; BONE MARROW CELL; BONE MARROW DERIVED MONONUCLEAR CELL; BREAST CARCINOMA; BREAST EPITHELIUM; CARCINOGENICITY; CELL COUNT; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CELL SURFACE; CONTROLLED STUDY; GENE DELETION; IMMUNE DEFICIENCY; LEWIS CARCINOMA; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; CYTOLOGY; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY; SECRETION (PROCESS); TUMOR CELL LINE; UDDER;

5'-NUCLEOTIDASE; ANIMALS; ANTIGENS, CD; APYRASE; BONE MARROW CELLS; CARCINOMA, LEWIS LUNG; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84921629667     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400578     Document Type: Article

References (52)

1. Feng, L., X. Sun, E. Csizmadia, L. Han, S. Bian, T. Murakami, X. Wang, S. C. Robson, and Y. Wu. 2011. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. Neoplasia 13: 206-216.
2. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5: 1249-1255.
3. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296: 301-305.
4. Beigi, R. D., S. B. Kertesy, G. Aquilina, and G. R. Dubyak. 2003. Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms. Br. J. Pharmacol. 140: 507-519.
5. Canaday, D. H., R. Beigi, R. F. Silver, C. V. Harding, W. H. Boom, and G. R. Dubyak. 2002. ATP and control of intracellular growth of mycobacteria by T cells. Infect. Immun. 70: 6456-6459.
6. Wilkin, F., X. Duhant, C. Bruyns, N. Suarez-Huerta, J. M. Boeynaems, and B. Robaye. 2001. The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J. Immunol. 166: 7172-7177.
7. Huang, S. P., G. J. Shieh, L. Lee, H. J. Teng, S. T. Kao, and J. G. Lin. 1997. Inhibition effect of shengma-gegen-tang on measles virus in Vero cells and human peripheral blood mononuclear cells. Am. J. Chin. Med. 25: 89-96.
8. Desai, A., C. Victor-Vega, S. Gadangi, M. C. Montesinos, C. C. Chu, and B. N. Cronstein. 2005. Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol. Pharmacol. 67: 1406-1413.
9. Novitskiy, S. V., S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein, Y. Huang, O. Y. Tikhomirov, M. R. Blackburn, I. Biaggioni, D. P. Carbone, I. Feoktistov, and M. M. Dikov. 2008. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 112: 1822-1831.
10. 2B) adenosine receptors promote carcinoma growth. Neoplasia 10: 987-995.
11. Borsellino, G., M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, R. Giometto, S. Höpner, D. Centonze, G. Bernardi, M. L. Dell'Acqua, et al. 2007. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232.
12. Deaglio, S., K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J. F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204: 1257-1265.
13. Ryzhov, S., S. V. Novitskiy, A. E. Goldstein, A. Biktasova, M. R. Blackburn, I. Biaggioni, M. M. Dikov, and I. Feoktistov. 2011. Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells. J. Immunol. 187: 6120-6129.
14. Koziak, K., E. Kaczmarek, A. Kittel, J. Sévigny, J. K. Blusztajn, J. Schulte Am Esch, II, M. Imai, O. Guckelberger, C. Goepfert, I. Qawi, and S. C. Robson. 2000. Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae. J. Biol. Chem. 275: 2057-2062.
15. Stella, J., L. Bavaresco, E. Braganhol, L. Rockenbach, P. F. Farias, M. R. Wink, A. A. Azambuja, C. H. Barrios, F. B. Morrone, and A. M. Oliveira Battastini. 2010. Differential ectonucleotidase expression in human bladder cancer cell lines. Urol. Oncol. 28: 260-267.
16. Jin, Q., L. X. Yuan, D. Boulbes, J. M. Baek, Y. N. Wang, D. Gomez-Cabello, D. H. Hawke, S. C. Yeung, M. H. Lee, G. N. Hortobagyi, et al. 2010. Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Res. 12: R96.
17. Clayton, A., S. Al-Taei, J. Webber, M. D. Mason, and Z. Tabi. 2011. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J. Immunol. 187: 676-683.
18. Teicher, B. A. 2001. Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev. 20: 133-143.
19. Dong, M., and G. C. Blobe. 2006. Role of transforming growth factor-beta in hematologic malignancies. Blood 107: 4589-4596.
20. Kim, B. G., C. Li, W. Qiao, M. Mamura, B. Kasprzak, M. Anver, L. Wolfraim, S. Hong, E. Mushinski, M. Potter, et al. 2006. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer [Published erratum appears in 2006. Nature 444: 780]. Nature 441: 1015-1019.
21. Li, M. O., and R. A. Flavell. 2008. TGF-beta: a master of all T cell trades. Cell 134: 392-404.
22. Novitskiy, S. V., M. W. Pickup, A. Chytil, D. Polosukhina, P. Owens, and H. L. Moses. 2012. Deletion of TGF-b signaling in myeloid cells enhances their anti-tumorigenic properties. J. Leukoc. Biol. 92: 641-651.
23. Novitskiy, S. V., M. W. Pickup, A. E. Gorska, P. Owens, A. Chytil, M. Aakre, H. Wu, Y. Shyr, and H. L. Moses. 2011. TGF-b receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms. Cancer Discov 1: 430-441.
24. Nagaraj, S., and D. I. Gabrilovich. 2010. Myeloid-derived suppressor cells in human cancer. Cancer J. 16: 348-353.
25. Gabrilovich, D. I., S. Ostrand-Rosenberg, and V. Bronte. 2012. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12: 253-268.
26. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555.
27. Qian, B. Z., and J. W. Pollard. 2010. Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
28. Hashimoto, D., J. Miller, and M. Merad. 2011. Dendritic cell and macrophage heterogeneity in vivo. Immunity 35: 323-335.
29. Dumitru, C. A., K. Moses, S. Trellakis, S. Lang, and S. Brandau. 2012. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol. Immunother. 61: 1155-1167.
30. Marigo, I., E. Bosio, S. Solito, C. Mesa, A. Fernandez, L. Dolcetti, S. Ugel, N. Sonda, S. Bicciato, E. Falisi, et al. 2010. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 32: 790-802.
31. Alvarez, R., and D. V. Daniels. 1992. A separation method for the assay of adenylylcyclase, intracellular cyclic AMP, and cyclic-AMP phosphodiesterase using tritium-labeled substrates. Anal. Biochem. 203: 76-82.
32. Jessen, K. A., S. Y. Liu, C. G. Tepper, J. Karrim, E. T. McGoldrick, A. Rosner, R. J. Munn, L. J. Young, A. D. Borowsky, R. D. Cardiff, and J. P. Gregg. 2004. Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Res. 6: R157-R169.
33. Antonioli, L., P. Pacher, E. S. Vizi, and G. Haskó. 2013. CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 19: 355-367.
34. Forrester, E., A. Chytil, B. Bierie, M. Aakre, A. E. Gorska, A. R. Sharif-Afshar, W. J. Muller, and H. L. Moses. 2005. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res. 65: 2296-2302.
35. Yang, L., J. Huang, X. Ren, A. E. Gorska, A. Chytil, M. Aakre, D. P. Carbone, L. M. Matrisian, A. Richmond, P. C. Lin, and H. L. Moses. 2008. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13: 23-35.
36. Gabrilovich, D. I., V. Bronte, S. H. Chen, M. P. Colombo, A. Ochoa, S. Ostrand-Rosenberg, and H. Schreiber. 2007. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 67: 425, author reply 426.
37. Mitchell, E. J., K. Lee, and M. D. O'Connor-McCourt. 1992. Characterization of transforming growth factor-beta (TGF-beta) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein. Mol. Biol. Cell 3: 1295-1307.
38. Koshiba, M., H. Kojima, S. Huang, S. Apasov, and M. V. Sitkovsky. 1997. Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells. J. Biol. Chem. 272: 25881-25889.
39. Raskovalova, T., X. Huang, M. Sitkovsky, L. C. Zacharia, E. K. Jackson, and E. Gorelik. 2005. Gs protein-coupled adenosine receptor signaling and lytic function of activated NK cells. J. Immunol. 175: 4383-4391.
40. Frentsch, M., O. Arbach, D. Kirchhoff, B. Moewes, M. Worm, M. Rothe, A. Scheffold, and A. Thiel. 2005. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat. Med. 11: 1118-1124.
41. Uhrberg, M. 2005. The CD107 mobilization assay: viable isolation and immunotherapeutic potential of tumor-cytolytic NK cells. Leukemia 19: 707-709.
42. Shevchenko, I., A. V. Bazhin, and V. Umansky. 2012. Comment on "Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b(+) Gr1(+) cells". J. Immunol. 188: 2929-2930; author reply 1930.
43. Pickup, M., S. Novitskiy, and H. L. Moses. 2013. The roles of TGFb in the tumour microenvironment. Nat. Rev. Cancer 13: 788-799.
44. Inman, G. J., F. J. Nicolás, J. F. Callahan, J. D. Harling, L. M. Gaster, A. D. Reith, N. J. Laping, and C. S. Hill. 2002. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62: 65-74.
45. Regateiro, F. S., D. Howie, K. F. Nolan, E. I. Agorogiannis, D. R. Greaves, S. P. Cobbold, and H. Waldmann. 2011. Generation of anti-inflammatory adenosine by leukocytes is regulated by TGF-b. Eur. J. Immunol. 41: 2955-2965.
46. Pang, Y., S. K. Gara, B. R. Achyut, Z. Li, H. H. Yan, C. P. Day, J. M. Weiss, G. Trinchieri, J. C. Morris, and L. Yang. 2013. TGF-b signaling in myeloid cells is required for tumor metastasis. Cancer Discov 3: 936-951.
47. Haskó, G., J. Linden, B. Cronstein, and P. Pacher. 2008. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7: 759-770.
48. Ryzhov, S., R. Zaynagetdinov, A. E. Goldstein, S. V. Novitskiy, M. R. Blackburn, I. Biaggioni, and I. Feoktistov. 2008. Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines. J. Pharmacol. Exp. Ther. 324: 694-700.
49. Herber, D. L., W. Cao, Y. Nefedova, S. V. Novitskiy, S. Nagaraj, V. A. Tyurin, A. Corzo, H. I. Cho, E. Celis, B. Lennox, et al. 2010. Lipid accumulation and dendritic cell dysfunction in cancer. Nat. Med. 16: 880-886.
50. Ohtaki, Y., G. Ishii, K. Nagai, S. Ashimine, T. Kuwata, T. Hishida, M. Nishimura, J. Yoshida, I. Takeyoshi, and A. Ochiai. 2010. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma. J. Thorac. Oncol. 5: 1507-1515.
51. Komohara, Y., H. Hasita, K. Ohnishi, Y. Fujiwara, S. Suzu, M. Eto, and M. Takeya. 2011. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci. 102: 1424-1431.
52. Shigeoka, M., N. Urakawa, T. Nakamura, M. Nishio, T. Watajima, D. Kuroda, T. Komori, Y. Kakeji, S. Semba, and H. Yokozaki. 2013. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. Cancer Sci. 104: 1112-1119.